Skip to navigation Skip to content

Share

Master Page Does Not Exist

    Services

    Master Page Does Not Exist
    1. Research Study to Compare Levels of Vitamin A & D in RRMS or SPMS

      We are conducting a research study to compare the level of vitamin A in relapsing remitting and secondary progressive multiple sclerosis patients who have a normal vitamin D level or are supplemented with Vitamin D to get them to a normal level.

      Torrance, CA 90502

    Resources

    Master Page Does Not Exist
    1. Promising MS Research - Recorded Webcast

      Promising MS Research to Repair, Protect and Restore the Nervous System. Moderator Kate Milliken and panelists Dr. Ben Barres, Dr. Jonah Chan, Dr. Timothy Coetzee and Dr. Rhonda Voskuhl. December 5, 2013

    2. Clinical Trials in MS

      Large Phase 3 trials in RR MS. Updated September 2013. Abbreviations Key: AAN – American Academy of Neurology. CIS – Clinically Isolated Syndrome.

    3. Find Clinical Trials

      Clinical trials help to find solutions for everyone affected by MS. Find studies near you.

    4. From Clinical Trials to Treatments

      This presentation is: From Clinical Trials to Treatments.

    5. Symptomatic Treatment Trials

      This document outlines Symptomatic Treatment Trials.

    6. "How the National MS Society Makes Funding Decisions" recorded teleconference

      Original Air Date: March 22, 2011 Presenter: Dr. Patricia O'Looney Research in MS is progressing at a remarkable rate, with more potential therapies in the pipeline than at any other time in history. The National MS Society is a driving force of MS research. Learn how far we've come, where we're going, and what the Society is doing to move toward a world free of MS.

    7. "MS Research Update" recorded teleconference

      Original Air Date: October 6, 2011

    8. MS Research Using Vision (OCT) Testing: Anti-LINGO-1 (video)

      Neuro-opthalmologist Tariq Bhatti, MD, at Duke University Eye Center, discusses the use of optical coherence tomography (OCT) in evaluating multiple sclerosis (MS) progression and the effects of treatments - namely anti-LINGO-1.

Share

Master Page Does Not Exist
© 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.